Main > ONCOLOGY (**) > Breast Cancer>MET *** > Treatment > Co: CH. R. Capecitabine Tab.>

---

Co: CH. R. Capecitabine Tab.>'s subsections
(*) USA Approval Date: 1998. 04.30
>+DoceTaxel after Failure of>
>MonoTherapy in Patients Resist.>
Company
Nucleoside Metabolic Inhibitor
Patent>Expiration Date: 2011. 01.13
ProDrug>Converts To 5-F Uracil
TradeMark
TradeMark Web-Site

Co: CH. R. Capecitabine Tab.>'s products
This section has no products